Global expansion: Hope to Filipino Cancer Patients
Updated: Apr 25, 2025
Medscore Expands Global Reach, Bringing Hope to Filipino Cancer Patients with technology.
[Manila, Philippines] – [November 25, 2024] – MedScore, a leading Tech provider of patient access solutions, launched innovative cancer patient access programs offered by global pharmaceutical company.
The program leverages MedScore's innovative affordability scoring solutions (means testing) with geo-location intelligence and banking-level underwriting to digitally assess patients across emerging markets, ensuring they receive the critical treatment they need.
MedScore empowers pharmaceutical companies to effectively reach their underserved patients in Vietnam and the Philippines.
By utilizing AI-powered scoring technology, MedScore can efficiently evaluate thousands of patients, streamlining the process and granting them access to breakthrough immunology treatment.
“Our mission is to bridge the gap between patients in need and life-saving medications,” said Olivia, CEO of MedScore. “With traditional low-digital methods often proving cumbersome and time-consuming, our technology offers a faster, more scalable solution specifically designed for the unique challenges of emerging markets.”
MedScore's comprehensive solution offers several key benefits:
Enhanced Efficiency: AI-powered assessments streamline the patient evaluation process, enabling pharmaceutical companies to reach a wider pool of qualified patients.
Improved Accuracy: Geo-location intelligence and banking-level underwriting ensure accurate patient selection for access programs.
Scalability: MedScore's technology can be seamlessly deployed across multiple countries and regions, maximizing program reach.
Faster Access to Treatment: By expediting the patient evaluation process, MedScore helps ensure patients receive timely access to critical treatment.
Media Contact:
Med.holdings Communications
